Is Lumentum (LITE) a risky stock?
As of July 27, 2026, Clavix grades Lumentum (LITE) C- for risk, a composite score of 57 out of 100 on an A+ to F scale, which puts LITE in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 27, 2026. Clavix regrades every trading day.
LITE price, last 3 months
LITE's daily closes over the past three months. Clavix reads risk from the fundamentals and news behind the price, not the line itself.
The five risk dimensions behind LITE's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how LITE scores on each, as of July 27, 2026.
What's moving LITE's risk right now
Company-specific signals Clavix flags behind LITE's current grade, drawn from recent news and filings as of July 27, 2026.
Two institutional investors opened new stakes in Lumentum, with Perseverance Asset Management investing about $17.6 million. The positions are relatively small and unlikely to move the stock on their own.
Barclays upgraded Lumentum and analysts expect the company to top earnings estimates in its next quarterly report. The setup could support the share price near-term, though recent trading has been volatile.
Lumentum was named as a stock that could benefit from large tech companies' AI infrastructure spending, particularly for optical networking and laser components used in hyperscaler data centers. This points to potential revenue growth.
Recent LITE news
The latest headlines Clavix ingested for Lumentum, newest first. These feed the news-sentiment dimension of LITE's grade.
What a C- grade means
On the Clavix A+ to F scale, LITE's composite of 57 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell LITE or any security. Grades are risk indicators, not predictions of return. Data may be delayed.